ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

P G Corrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.